Matches in Wikidata for { <http://www.wikidata.org/entity/Q85158798> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- Q85158798 description "artículu científicu espublizáu n'ochobre de 2010" @default.
- Q85158798 description "scientific article published on 04 October 2010" @default.
- Q85158798 description "wetenschappelijk artikel" @default.
- Q85158798 description "наукова стаття, опублікована в жовтні 2010" @default.
- Q85158798 name "Gemcitabine and docetaxel in metastatic, castrate-resistant prostate cancer: results from a phase 2 trial" @default.
- Q85158798 name "Gemcitabine and docetaxel in metastatic, castrate-resistant prostate cancer: results from a phase 2 trial" @default.
- Q85158798 type Item @default.
- Q85158798 label "Gemcitabine and docetaxel in metastatic, castrate-resistant prostate cancer: results from a phase 2 trial" @default.
- Q85158798 label "Gemcitabine and docetaxel in metastatic, castrate-resistant prostate cancer: results from a phase 2 trial" @default.
- Q85158798 prefLabel "Gemcitabine and docetaxel in metastatic, castrate-resistant prostate cancer: results from a phase 2 trial" @default.
- Q85158798 prefLabel "Gemcitabine and docetaxel in metastatic, castrate-resistant prostate cancer: results from a phase 2 trial" @default.
- Q85158798 P1433 Q85158798-8B9154B8-0835-47B9-859F-EC2B4A8BE5C7 @default.
- Q85158798 P1476 Q85158798-3A5E3290-34E3-49A1-A222-D6B7AE0E4496 @default.
- Q85158798 P2093 Q85158798-17FBDE64-2591-4716-9E1D-B188FA244D18 @default.
- Q85158798 P2093 Q85158798-37574C3A-46EC-4C3B-B92F-A3F496708CA7 @default.
- Q85158798 P2093 Q85158798-8BF71BC4-CD84-425C-B41D-EFA261C58DBC @default.
- Q85158798 P2093 Q85158798-D1BD699A-EA40-41DB-AEC4-BEFAA2E6D92B @default.
- Q85158798 P2093 Q85158798-DA105564-C6FF-4C2F-BE99-43ED48BE90A3 @default.
- Q85158798 P2860 Q85158798-072A260E-95BB-44B3-AE23-87B9C9389BAE @default.
- Q85158798 P2860 Q85158798-09398E07-498E-44B6-BBF7-9EEE465802DE @default.
- Q85158798 P2860 Q85158798-09F6CCE1-0E04-48BA-B078-BAA536FE808C @default.
- Q85158798 P2860 Q85158798-0D225973-59BB-43B4-878C-0CEA232DCA2C @default.
- Q85158798 P2860 Q85158798-0F9059B5-ADC9-411D-84A7-E54AA5AC20F0 @default.
- Q85158798 P2860 Q85158798-2A596539-EA2E-477A-828A-A8B80A5D789C @default.
- Q85158798 P2860 Q85158798-352BF594-2080-428E-93E4-865D5F406C9C @default.
- Q85158798 P2860 Q85158798-49A86A21-2CF9-486E-B2DC-3C47F93E477B @default.
- Q85158798 P2860 Q85158798-545B7626-7B33-43C2-89F3-646A3E6272B7 @default.
- Q85158798 P2860 Q85158798-563B4614-D181-43E9-AA8D-D0FBB65DC270 @default.
- Q85158798 P2860 Q85158798-5920DE1D-B8BA-458A-86AC-29B242EAB47F @default.
- Q85158798 P2860 Q85158798-733E1698-3077-49C8-AE2C-04466D423016 @default.
- Q85158798 P2860 Q85158798-7E856756-0122-4F3A-AA98-5AD1B68B29E1 @default.
- Q85158798 P2860 Q85158798-85AEB0D0-EACC-4D46-869F-8BA21EFC0626 @default.
- Q85158798 P2860 Q85158798-99D377D5-64F4-4226-8467-629BD39DC51E @default.
- Q85158798 P2860 Q85158798-ADAB6838-78D3-4B83-B12A-A8C1B0178457 @default.
- Q85158798 P2860 Q85158798-C818C18A-889C-4387-A57E-1DB34579EA80 @default.
- Q85158798 P2860 Q85158798-DF149C04-AED5-418F-B1C3-94CC0F409BF1 @default.
- Q85158798 P304 Q85158798-76098B2B-AFD1-4CD4-BBD1-CAE24AFCA47B @default.
- Q85158798 P31 Q85158798-80C64965-BBD0-4CFB-B9F4-F1156B21155C @default.
- Q85158798 P356 Q85158798-8E599517-4B73-4EDF-A9D8-3D750D047C3D @default.
- Q85158798 P433 Q85158798-436F5E25-2C01-482A-A13B-328F1C1E2FA2 @default.
- Q85158798 P478 Q85158798-B6394FCB-B242-4971-A364-2412D3142501 @default.
- Q85158798 P577 Q85158798-2B8F8855-DB92-4FDF-B6DD-DF65675B849B @default.
- Q85158798 P698 Q85158798-57982B91-58D1-450A-926F-EE2FB734BB3D @default.
- Q85158798 P921 Q85158798-3731068D-F92B-4CC1-AE40-F75AE696D23E @default.
- Q85158798 P921 Q85158798-3E68B77F-7487-4CF8-8131-A701AB39AA0E @default.
- Q85158798 P921 Q85158798-4FA8C143-CD8A-4413-BA3F-DB8FACEC1FAD @default.
- Q85158798 P356 CNCR.25457 @default.
- Q85158798 P698 20922803 @default.
- Q85158798 P1433 Q326041 @default.
- Q85158798 P1476 "Gemcitabine and docetaxel in metastatic, castrate-resistant prostate cancer: results from a phase 2 trial" @default.
- Q85158798 P2093 "Dale Shepard" @default.
- Q85158798 P2093 "Jorge A Garcia" @default.
- Q85158798 P2093 "Paul Elson" @default.
- Q85158798 P2093 "Robert Dreicer" @default.
- Q85158798 P2093 "Thomas E Hutson" @default.
- Q85158798 P2860 Q24605577 @default.
- Q85158798 P2860 Q27860904 @default.
- Q85158798 P2860 Q29547625 @default.
- Q85158798 P2860 Q29616123 @default.
- Q85158798 P2860 Q29616218 @default.
- Q85158798 P2860 Q33345788 @default.
- Q85158798 P2860 Q33347643 @default.
- Q85158798 P2860 Q33349326 @default.
- Q85158798 P2860 Q33566395 @default.
- Q85158798 P2860 Q34985979 @default.
- Q85158798 P2860 Q36504117 @default.
- Q85158798 P2860 Q37606741 @default.
- Q85158798 P2860 Q40558439 @default.
- Q85158798 P2860 Q43250802 @default.
- Q85158798 P2860 Q44491255 @default.
- Q85158798 P2860 Q54055764 @default.
- Q85158798 P2860 Q60156373 @default.
- Q85158798 P2860 Q94704301 @default.
- Q85158798 P304 "752-757" @default.
- Q85158798 P31 Q13442814 @default.
- Q85158798 P356 "10.1002/CNCR.25457" @default.
- Q85158798 P433 "4" @default.
- Q85158798 P478 "117" @default.
- Q85158798 P577 "2010-10-04T00:00:00Z" @default.
- Q85158798 P698 "20922803" @default.
- Q85158798 P921 Q181257 @default.
- Q85158798 P921 Q420436 @default.
- Q85158798 P921 Q42824440 @default.